You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. AstraZeneca and Daiichi's Enhertu shows pCR rate improvement in breast cancer trial
- 2. BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
- 3. UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers
- 4. Incidence of several early-onset cancers increased between 2010 and 2019
- 5. Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
- 6. Dr Boreham's Crucible: The strategy is clear for this x-ray imaging house – can it see it through to profitability?
- 7. Health Check: Neuren says more patients are staying the course as US Daybue sales lift
- 8. Thromboembolic Events in Castration-Resistant Prostate Cancer Patients With and Without Cardiovascular Comorbidities Receiving Oral Androgen Receptor Pathway Inhibitors.
- 9. Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
- 10. Genitourinary Drugs Market Projected to Hit USD 33.37 Billion by 2032, Driven by Rising Cancer Rates and Urinary Disorders Worldwide | SNS Insider
Last updated at 5:41 GMT
Hot News Makers
Health/Pharma Companies
-
147394.91
-
41687.07
-
37768.93
-
23639.68
-
21920.03
-
18452.39
-
8818.86
-
8011.55
-
8002.77
-
7074.59
Drugs, Treatments, Trials
-
34443.12
-
9557.12
-
7152.57
-
6971.76
-
6620.97
-
4953.82
-
4334.47
-
3733.12
-
2710.36
-
1912.50
Last updated at 5:10 GMT
